← All companies

AVCR

Avricore Health Inc.

AVCRF OTC Pharmaceutical Preparations EDGAR ↗

$0.03

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$2.53M

Revenue (TTM)

—

Net income (TTM)

-$1.17M

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.02 – $0.08

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 13, 2026 6-K Jun 11, 2026 6-K May 11, 2026 6-K Feb 17, 2026 6-K Jan 12, 2026 6-K Dec 10, 2025 6-K Sep 15, 2025 6-K Aug 8, 2025 6-K Jul 11, 2025 20-F Jun 16, 2025 6-K Jun 5, 2025 6-K May 20, 2025 6-K Feb 6, 2025 6-K Dec 5, 2024 6-K Oct 7, 2024 6-K Sep 6, 2024 6-K Jul 9, 2024 6-K Jun 20, 2024 20-F Jun 12, 2024 6-K May 8, 2024 6-K Dec 6, 2023 6-K Oct 11, 2023 6-K Sep 13, 2023 6-K Aug 3, 2023 6-K Jul 10, 2023 20-F Jun 16, 2023 6-K Jun 8, 2023 6-K May 5, 2023 6-K Apr 5, 2023 6-K Mar 13, 2023 6-K Jan 13, 2023 6-K Jan 12, 2023 6-K Jan 6, 2023 6-K Jan 6, 2023 6-K Dec 30, 2022 6-K Dec 23, 2022 20-F Dec 20, 2022 6-K Oct 14, 2022 6-K Oct 14, 2022 6-K Oct 13, 2022